Vanderbilt-Ingram Cancer Center: all 223 studies

Page 2 of 3. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00425750Phase 2Results posted
• Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast CancerTerminatedNCT00343512Phase 2Results posted
• Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary NodulesActive, not recruitingNCT06638398Not applicable
• Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL TrialActive, not recruitingNCT06593106Not applicable
• Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung CancerTerminatedNCT06140407Phase 2
• A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary NodulesActive, not recruitingNCT06074133
• Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney CancerCompletedNCT04883827
• Improving Care After Inherited Cancer TestingActive, not recruitingNCT04763915Not applicable
• Reversal of Preneoplastic Metaplasia in the Stomach With MEK InhibitorActive, not recruitingNCT04454476Phase 1
• COVID-19 and Cancer Consortium RegistryActive, not recruitingNCT04354701
• Yoga Intervention in Head and Neck Cancer Patients Undergoing Concurrent Chemo-RadiationTerminatedNCT04146779Not applicable
• Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel FrequencyTerminatedNCT04073017Not applicable
• PCRC-Supported Legacy Intervention in Pediatric Palliative CareCompletedNCT04059393Not applicable
• Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy InfusionTerminatedNCT04034914Not applicable
• ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid LeukemiaWithdrawnNCT04013880Phase 1/2
• A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast CancerCompletedNCT03962647Early Phase 1
• Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersTerminatedNCT03924245Phase 1
• Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their ParentsCompletedNCT03765099Not applicable
• Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceActive, not recruitingNCT03694249Phase 2
• Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT03652233Phase 1
• Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System LymphomaTerminatedNCT03558750Phase 1
• Circulating Blood Profile to Predict Recurrence and Response to Systemic TherapyCompletedNCT03267381
• Early Detection of Lung CancerActive, not recruitingNCT03181256
• Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT03054038Phase 1
• Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation LoadsWithdrawnNCT03023904Phase 2
• Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerTerminatedNCT02937402Not applicable
• Hatha Yoga in Breast Cancer SurvivorsTerminatedNCT02923037Not applicable
• PET Imaging of Ovarian Carcinoma With 18F-FSPGWithdrawnNCT02872519Early Phase 1
• Visually Enhanced Education About Prostate CancerCompletedNCT02846870Not applicable
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
• Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis FungoidesSuspendedNCT02702310
• Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyCompletedNCT02685631
• Impact of Pleural Manometry on Chest Discomfort After Therapeutic ThoracentesisCompletedNCT02677883Not applicable
• Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and FibrosisCompletedNCT02676752
• Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast CancerCompletedNCT02672475Phase 1
• TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to HydroxyureaCompletedNCT02493530Phase 1
• Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their CaregiversTerminatedNCT02440737Not applicable
• Establishing Lymphedema and Fibrosis Measures in Oral Cancer PatientsCompletedNCT02412241Not applicable
• 18F-FES PET/CT in Imaging Patients With Desmoid TumorsTerminatedNCT02374931Early Phase 1
• Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02324881Not applicable
• Quantitative MRI in Assessing Disease in Patients With Brain TumorsTerminatedNCT02269111Not applicable
• Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell TransplantTerminatedNCT02240381Not applicable
• Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer SurvivorsTerminatedNCT02170272Not applicable
• Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)TerminatedNCT02151539
• Programs to Support You During Chemotherapy (Pro-You)CompletedNCT02148406Not applicable
• 3T MRI Biomarkers of Glioma Treatment ResponseTerminatedNCT01996527Early Phase 1
• Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer SurvivorsCompletedNCT01951664Not applicable
• Ultra High Field MRI and MRS Techniques in Diagnosing Breast CancerTerminatedNCT01938651Not applicable
• Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibWithdrawnNCT01928160Phase 2
• ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia PatientsCompletedNCT01901367Not applicable
• A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade GliomaCompletedNCT01891747Phase 1
• Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing SarcomaTerminatedNCT01882231Not applicable
• BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT01791478Phase 1
• Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerTerminatedNCT01707823Early Phase 1
• Nashville Early Diagnosis Lung Cancer ProjectActive, not recruitingNCT01475500
• Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal PhotophoresisTerminatedNCT01324908Not applicable
• Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain MetastasesCompletedNCT01276210Phase 1
• PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast CancerCompletedNCT01248494Phase 1
• Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast CancerWithdrawnNCT01240941Phase 2
• MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast CancerWithdrawnNCT01240928Phase 1
• Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and ProtocolCompletedNCT01230515
• Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal CancerCompletedNCT01207895Phase 1
• Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked CigarettesTerminatedNCT01141218
• Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving PaclitaxelTerminatedNCT01096407
• Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorTerminatedNCT01096381
• Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerWithdrawnNCT01013506Phase 2
• Opioids Titration in Hospice PatientsWithdrawnNCT01007422
• Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
• Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerCompletedNCT00983268Phase 1
• Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00957736
• Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerTerminatedNCT00949052
• Prostaglandin Metabolite in Urine Samples From Patients With Ovarian CancerCompletedNCT00900523
• Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantCompletedNCT00900406
• Studying Biomarkers in Patients With Pancreatic CancerCompletedNCT00900003
• Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy ParticipantsCompletedNCT00899457
• Protein Expression in Tumor Tissue Samples From Patients With Cancer of the OropharynxCompletedNCT00899340
• Biomarkers in Stored Tumor Samples From Younger Patients With Liver CancerWithdrawnNCT00899002
• Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck CancerTerminatedNCT00898742
• DNA Analysis of Tissue Samples From Patients With Head and Neck CancerCompletedNCT00898664
• Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyTerminatedNCT00898430
• Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)TerminatedNCT00898209
• Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With CancerTerminatedNCT00898027
• Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic CancerCompletedNCT00897832
• Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerCompletedNCT00897793
• Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung CancerCompletedNCT00897650
• Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast CancerCompletedNCT00897468
• Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn DiseaseTerminatedNCT00897312
• Gene Expression Profiles in Predicting Survival of Patients With Head and Neck CancerCompletedNCT00897052
• Immunoreactivity to Cetuximab in Cancer PatientsCompletedNCT00896896
• Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell CancerCompletedNCT00896675
• Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202CompletedNCT00896662
• Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung CancerTerminatedNCT00892801Phase 1
• PET Study in Patients With Non-Hodgkin LymphomaCompletedNCT00712556
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
• Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and ProteomicsCompletedNCT00656604Not applicable
• Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck CancerCompletedNCT00655005
• Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00653250Not applicable
• Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryTerminatedNCT00651976Early Phase 1
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
• Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00647218Not applicable

← Vanderbilt-Ingram Cancer Center overview and focus areas